Cargando…
An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods
INTRODUCTION: Xeroderma pigmentosum (XP) is a rare genetic condition caused by defective nucleotide excision repair and characterised by skin cancer, ocular and neurological involvement. Stringent ultraviolet protection is the only way to prevent skin cancer. Despite the risks, some patients’ photop...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724163/ https://www.ncbi.nlm.nih.gov/pubmed/28827277 http://dx.doi.org/10.1136/bmjopen-2017-018364 |
_version_ | 1783285312872513536 |
---|---|
author | Walburn, Jessica Sarkany, Robert Norton, Sam Foster, Lesley Morgan, Myfanwy Sainsbury, Kirby Araújo-Soares, Vera Anderson, Rebecca Garrood, Isabel Heydenreich, Jakob Sniehotta, Falko F Vieira, Rute Wulf, Hans Christian Weinman, John |
author_facet | Walburn, Jessica Sarkany, Robert Norton, Sam Foster, Lesley Morgan, Myfanwy Sainsbury, Kirby Araújo-Soares, Vera Anderson, Rebecca Garrood, Isabel Heydenreich, Jakob Sniehotta, Falko F Vieira, Rute Wulf, Hans Christian Weinman, John |
author_sort | Walburn, Jessica |
collection | PubMed |
description | INTRODUCTION: Xeroderma pigmentosum (XP) is a rare genetic condition caused by defective nucleotide excision repair and characterised by skin cancer, ocular and neurological involvement. Stringent ultraviolet protection is the only way to prevent skin cancer. Despite the risks, some patients’ photoprotection is poor, with a potentially devastating impact on their prognosis. The aim of this research is to identify disease-specific and psychosocial predictors of photoprotection behaviour and ultraviolet radiation (UVR) dose to the face. METHODS AND ANALYSIS: Mixed methods research based on 45 UK patients will involve qualitative interviews to identify individuals’ experience of XP and the influences on their photoprotection behaviours and a cross-sectional quantitative survey to assess biopsychosocial correlates of these behaviours at baseline. This will be followed by objective measurement of UVR exposure for 21 days by wrist-worn dosimeter and daily recording of photoprotection behaviours and psychological variables for up to 50 days in the summer months. This novel methodology will enable UVR dose reaching the face to be calculated and analysed as a clinically relevant endpoint. A range of qualitative and quantitative analytical approaches will be used, reflecting the mixed methods (eg, cross-sectional qualitative interviews, n-of-1 studies). Framework analysis will be used to analyse the qualitative interviews; mixed-effects longitudinal models will be used to examine the association of clinical and psychosocial factors with the average daily UVR dose; dynamic logistic regression models will be used to investigate participant-specific psychosocial factors associated with photoprotection behaviours. ETHICS AND DISSEMINATION: This research has been approved by Camden and King’s Cross Research Ethics Committee 15/LO/1395. The findings will be published in peer-reviewed journals and presented at national and international scientific conferences. |
format | Online Article Text |
id | pubmed-5724163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57241632017-12-19 An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods Walburn, Jessica Sarkany, Robert Norton, Sam Foster, Lesley Morgan, Myfanwy Sainsbury, Kirby Araújo-Soares, Vera Anderson, Rebecca Garrood, Isabel Heydenreich, Jakob Sniehotta, Falko F Vieira, Rute Wulf, Hans Christian Weinman, John BMJ Open Dermatology INTRODUCTION: Xeroderma pigmentosum (XP) is a rare genetic condition caused by defective nucleotide excision repair and characterised by skin cancer, ocular and neurological involvement. Stringent ultraviolet protection is the only way to prevent skin cancer. Despite the risks, some patients’ photoprotection is poor, with a potentially devastating impact on their prognosis. The aim of this research is to identify disease-specific and psychosocial predictors of photoprotection behaviour and ultraviolet radiation (UVR) dose to the face. METHODS AND ANALYSIS: Mixed methods research based on 45 UK patients will involve qualitative interviews to identify individuals’ experience of XP and the influences on their photoprotection behaviours and a cross-sectional quantitative survey to assess biopsychosocial correlates of these behaviours at baseline. This will be followed by objective measurement of UVR exposure for 21 days by wrist-worn dosimeter and daily recording of photoprotection behaviours and psychological variables for up to 50 days in the summer months. This novel methodology will enable UVR dose reaching the face to be calculated and analysed as a clinically relevant endpoint. A range of qualitative and quantitative analytical approaches will be used, reflecting the mixed methods (eg, cross-sectional qualitative interviews, n-of-1 studies). Framework analysis will be used to analyse the qualitative interviews; mixed-effects longitudinal models will be used to examine the association of clinical and psychosocial factors with the average daily UVR dose; dynamic logistic regression models will be used to investigate participant-specific psychosocial factors associated with photoprotection behaviours. ETHICS AND DISSEMINATION: This research has been approved by Camden and King’s Cross Research Ethics Committee 15/LO/1395. The findings will be published in peer-reviewed journals and presented at national and international scientific conferences. BMJ Publishing Group 2017-08-21 /pmc/articles/PMC5724163/ /pubmed/28827277 http://dx.doi.org/10.1136/bmjopen-2017-018364 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Dermatology Walburn, Jessica Sarkany, Robert Norton, Sam Foster, Lesley Morgan, Myfanwy Sainsbury, Kirby Araújo-Soares, Vera Anderson, Rebecca Garrood, Isabel Heydenreich, Jakob Sniehotta, Falko F Vieira, Rute Wulf, Hans Christian Weinman, John An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods |
title | An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods |
title_full | An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods |
title_fullStr | An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods |
title_full_unstemmed | An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods |
title_short | An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods |
title_sort | investigation of the predictors of photoprotection and uvr dose to the face in patients with xp: a protocol using observational mixed methods |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724163/ https://www.ncbi.nlm.nih.gov/pubmed/28827277 http://dx.doi.org/10.1136/bmjopen-2017-018364 |
work_keys_str_mv | AT walburnjessica aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT sarkanyrobert aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT nortonsam aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT fosterlesley aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT morganmyfanwy aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT sainsburykirby aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT araujosoaresvera aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT andersonrebecca aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT garroodisabel aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT heydenreichjakob aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT sniehottafalkof aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT vieirarute aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT wulfhanschristian aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT weinmanjohn aninvestigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT walburnjessica investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT sarkanyrobert investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT nortonsam investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT fosterlesley investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT morganmyfanwy investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT sainsburykirby investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT araujosoaresvera investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT andersonrebecca investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT garroodisabel investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT heydenreichjakob investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT sniehottafalkof investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT vieirarute investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT wulfhanschristian investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods AT weinmanjohn investigationofthepredictorsofphotoprotectionanduvrdosetothefaceinpatientswithxpaprotocolusingobservationalmixedmethods |